Skip to main content
Erschienen in: Calcified Tissue International 1/2010

01.01.2010

The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis

verfasst von: J. Paccou, N. Zeboulon, C. Combescure, L. Gossec, B. Cortet

Erschienen in: Calcified Tissue International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density for adult patients with cystic fibrosis. Fracture complications were also described. The objective of this study was to determine the prevalence of osteoporosis, osteopenia, and fractures among adult patients with cystic fibrosis. A systematic literature review was conducted using electronic databases. The keywords used were “cystic fibrosis [MeSH] AND bone density.” Original studies were eligible if they reported the prevalence of osteoporosis and/or osteopenia and/or fractures in adult patients with cystic fibrosis. A meta-analysis of pooled proportions was performed. Heterogeneity was tested with the Cochran Q statistic, and in the case of heterogeneity a random effect model was used. Of 117 studies, 12 were selected, i.e., that represented a total of 1055 patients. Mean age ranged from 18.5 to 32 years (median: 28.2 years). Mean body mass index ranged from 19.9 to 22.4 (median: 20.7); 53.8% were men. The pooled prevalence of osteoporosis in adults with cystic fibrosis was 23.5% (95% CI, 16.6–31.0). The pooled prevalence of osteopenia was 38% (95% CI, 28.2–48.3). The pooled prevalences of radiological vertebral fractures and nonvertebral fractures were 14% (95% CI, 7.8–21.7) and 19.7% (95% CI, 6.0–38.8), respectively. In conclusion, this systematic literature review with meta-analysis emphasized the high prevalence of osteopenia and osteoporosis in young adults with cystic fibrosis. The prevalence of fracture was also high.
Literatur
2.
Zurück zum Zitat Frederiksen B, Lang S, Koch C, Hoiby N (1996) Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 21:153–158CrossRefPubMed Frederiksen B, Lang S, Koch C, Hoiby N (1996) Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 21:153–158CrossRefPubMed
3.
Zurück zum Zitat Conway SP, Morton AM, Oldroyd B et al (2000) Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55:798–804CrossRefPubMed Conway SP, Morton AM, Oldroyd B et al (2000) Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55:798–804CrossRefPubMed
4.
Zurück zum Zitat Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J (1999) Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 81:235–240CrossRefPubMed Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J (1999) Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 81:235–240CrossRefPubMed
5.
Zurück zum Zitat Donovan DS Jr, Papadopoulos A, Staron RB et al (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157:1892–1899PubMed Donovan DS Jr, Papadopoulos A, Staron RB et al (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157:1892–1899PubMed
6.
Zurück zum Zitat Haworth CS, Selby PL, Webb AK et al (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54:961–967PubMed Haworth CS, Selby PL, Webb AK et al (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54:961–967PubMed
7.
Zurück zum Zitat Aris RM, Renner JB, Winders AD et al (1998) Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128:186–193PubMed Aris RM, Renner JB, Winders AD et al (1998) Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128:186–193PubMed
8.
Zurück zum Zitat Henderson RC, Specter BB (1994) Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 125:208–212CrossRefPubMed Henderson RC, Specter BB (1994) Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 125:208–212CrossRefPubMed
9.
Zurück zum Zitat Stuart A, Ord JK (1994) Kendall’s advanced theory of statistics, 6th edn. Edward Arnold, London Stuart A, Ord JK (1994) Kendall’s advanced theory of statistics, 6th edn. Edward Arnold, London
10.
Zurück zum Zitat Egger M, Davey Smith G, Altman DG (eds) (2001) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Books, London Egger M, Davey Smith G, Altman DG (eds) (2001) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Books, London
11.
Zurück zum Zitat Brenckmann C, Papaioannou A, Freitag A et al (2003) Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study. BMC Musculoskel Disord 4–13 Brenckmann C, Papaioannou A, Freitag A et al (2003) Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study. BMC Musculoskel Disord 4–13
12.
Zurück zum Zitat Stephenson A, Jamal S, Dowdell T et al (2006) Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 130:539–544CrossRefPubMed Stephenson A, Jamal S, Dowdell T et al (2006) Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 130:539–544CrossRefPubMed
13.
Zurück zum Zitat King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, Wilson JW (2005) Reduced bone density in cystic fibrosis:DeltaF508 mutation is an independent risk factor. Eur Respir J 25:54–61CrossRefPubMed King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, Wilson JW (2005) Reduced bone density in cystic fibrosis:DeltaF508 mutation is an independent risk factor. Eur Respir J 25:54–61CrossRefPubMed
14.
Zurück zum Zitat Rossini M, Del Marco A, Dal Santo F et al (2004) Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone 35:771–776CrossRefPubMed Rossini M, Del Marco A, Dal Santo F et al (2004) Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone 35:771–776CrossRefPubMed
15.
Zurück zum Zitat Flohr F, Lutz A, App EM, Matthys H, Reincke M (2002) Bone mineral density and quantitative ultrasound in adults with cystic fibrosis. Eur J Endocrinol 146:531–536CrossRefPubMed Flohr F, Lutz A, App EM, Matthys H, Reincke M (2002) Bone mineral density and quantitative ultrasound in adults with cystic fibrosis. Eur J Endocrinol 146:531–536CrossRefPubMed
16.
Zurück zum Zitat Ionescu AA, Nixon LS, Evans WD et al (2000) Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 162:789–794PubMed Ionescu AA, Nixon LS, Evans WD et al (2000) Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 162:789–794PubMed
17.
Zurück zum Zitat Grey AB, Ames RW, Matthews RD, Reid IR (1993) Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 48:589–593CrossRefPubMed Grey AB, Ames RW, Matthews RD, Reid IR (1993) Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 48:589–593CrossRefPubMed
18.
Zurück zum Zitat Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, Compston JE, Hodson ME (2001) Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12:366–372CrossRefPubMed Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, Compston JE, Hodson ME (2001) Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12:366–372CrossRefPubMed
19.
Zurück zum Zitat Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester G (2002) Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 13:151–157CrossRefPubMed Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester G (2002) Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 13:151–157CrossRefPubMed
20.
Zurück zum Zitat Lang SM, Fischer R, Stratakis DF, Huber RM (2004) High prevalence of osteoporosis in adult cystic fibrosis patients. Dtsch Med Wochenschr 129:1551–1555CrossRefPubMed Lang SM, Fischer R, Stratakis DF, Huber RM (2004) High prevalence of osteoporosis in adult cystic fibrosis patients. Dtsch Med Wochenschr 129:1551–1555CrossRefPubMed
21.
Zurück zum Zitat Liberman UA, Weiss SR, Broll J et al (1995) Effect of oral alendronate on BMD and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437–1443CrossRefPubMed Liberman UA, Weiss SR, Broll J et al (1995) Effect of oral alendronate on BMD and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437–1443CrossRefPubMed
22.
Zurück zum Zitat Black DM, Cummings SR, Karpf DB et al (1996) Effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541CrossRefPubMed Black DM, Cummings SR, Karpf DB et al (1996) Effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541CrossRefPubMed
23.
Zurück zum Zitat Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984–996PubMedCrossRef Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:984–996PubMedCrossRef
24.
Zurück zum Zitat Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ III (1991) Classification of vertebral fractures. J Bone Miner Res 6:207–215PubMed Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ III (1991) Classification of vertebral fractures. J Bone Miner Res 6:207–215PubMed
25.
Zurück zum Zitat Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK (1998) Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 133:18–27CrossRefPubMed Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK (1998) Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 133:18–27CrossRefPubMed
26.
Zurück zum Zitat Lutz A, Flohr F, Reincke M, Fischer C, App E (2001) Rapid loss of bone density in lumbar spines of adult patients with cystic fibrosis. Exp Clin Endocrinol Diabetes 109:23CrossRef Lutz A, Flohr F, Reincke M, Fischer C, App E (2001) Rapid loss of bone density in lumbar spines of adult patients with cystic fibrosis. Exp Clin Endocrinol Diabetes 109:23CrossRef
27.
Zurück zum Zitat Chapman I, Greville H, Ebeling P, King S Kotsimbos T, Nugent P, Player R, Topliss D, Warner J, Wilson J (2008) Intravenous zoledronate improves bone density in adults with cystic fibrosis. Clin Endocrinol (Oxford) (Epub ahead of print) Chapman I, Greville H, Ebeling P, King S Kotsimbos T, Nugent P, Player R, Topliss D, Warner J, Wilson J (2008) Intravenous zoledronate improves bone density in adults with cystic fibrosis. Clin Endocrinol (Oxford) (Epub ahead of print)
28.
Zurück zum Zitat Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O’Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD (2008) Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patient (CFOS trial). Chest 134:794–800CrossRefPubMed Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O’Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD (2008) Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patient (CFOS trial). Chest 134:794–800CrossRefPubMed
Metadaten
Titel
The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis
verfasst von
J. Paccou
N. Zeboulon
C. Combescure
L. Gossec
B. Cortet
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 1/2010
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-009-9316-9

Weitere Artikel der Ausgabe 1/2010

Calcified Tissue International 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.